|
XPO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.435600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.034100E-02 |
| Normal-vs-Stage2 |
5.794400E-04 |
| Normal-vs-Stage3 |
5.91340000000162E-05 |
| Normal-vs-Stage4 |
4.780200E-02 |
| Stage1-vs-Stage2 |
2.152200E-02 |
| Stage1-vs-Stage3 |
3.084500E-03 |
| Stage1-vs-Stage4 |
4.253000E-01 |
| Stage2-vs-Stage3 |
8.636600E-01 |
| Stage2-vs-Stage4 |
2.471600E-01 |
| Stage3-vs-Stage4 |
2.280400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.081500E-03 |
| Normal-vs-AfricanAmerican |
2.428000E-02 |
| Normal-vs-Asian |
3.772600E-01 |
| Caucasian-vs-AfricanAmerican |
6.745200E-01 |
| Caucasian-vs-Asian |
2.343800E-01 |
| AfricanAmerican-vs-Asian |
2.320000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.358440E-02 |
| Normal-vs-Female |
2.838300E-03 |
| Male-vs-Female |
8.709600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.551800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.202000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.436300E-04 |
| Normal-vs-Age(81-100Yrs) |
5.93209999999456E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.959200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.562600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.649800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.855200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.028000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.529600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.568000E-02 |
| Classical-VS-Follicular |
6.835800E-02 |
| Classical-VS-Other |
4.104800E-01 |
| Classical-VS-Normal |
5.649800E-02 |
| Tall-VS-Follicular |
5.272800E-01 |
| Tall-VS-Other |
4.627700E-02 |
| Tall-VS-Normal |
6.778400E-04 |
| Follicular-VS-Other |
2.483800E-01 |
| Follicular-VS-Normal |
3.864100E-03 |
| Other-VS-Normal |
9.697200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.776200E-04 |
| Normal-vs-N1 |
4.485600E-02 |
| N0-vs-N1 |
5.289800E-01 |
|
|
